Amid Trump victory, women's health providers see flood of orders for contraception, abortion pills

Women’s health providers are reporting a major surge in emergency contraception, birth control and medication abortion sales since the election last week.

Donald Trump's victory, along with the Republican Party taking the Senate, will make abortion rights more vulnerable. Though Trump had previously said that abortion is an issue for the states, not the federal government, more recently he has not ruled out leaning on the FDA to revoke its approval of the medication abortion pill mifepristone. 

Though almost surely to be challenged in court—given more than half of abortions in the U.S. are done via medication today—the move would be consequential. Even where the legal implications for providing a healthcare service are unclear, fear of prosecution alone has been enough to deter providers. Trump has also flip-flopped on whether he would attempt to restrict access to birth control, and reproductive rights advocates are worried.

Though providers also saw a jump in reproductive health care sales following the Supreme Court's overturning of Roe v. Wade, many say the latest numbers exceed that. Monica Cepak, CEO of sexual and reproductive care provider Wisp, told Fierce Healthcare the company had its biggest revenue day on the day after the election.

Read Full Article Here